Bacillus Clausii for Gut Health

Research suggests that Bacillus clausii may support gut health, particularly in contexts where the microbiome has been disrupted by medications or other stressors. A 2023 laboratory study using a simulated human gut model found that Bacillus clausii supplementation — both alongside and following proton pump inhibitor use — was associated with improvements in microbial balance and increased butyrate production, a marker of gut health, though the researchers noted this evidence comes from an in vitro system rather than a human clinical trial. A 2023 review further supports the general premise that probiotics, including spore-forming strains like Bacillus clausii, show promise in reducing antibiotic-associated diarrhea and aiding gut recovery following microbiome disruption, though it stops short of making strain-specific clinical recommendations. The available evidence is largely preliminary — consisting of a laboratory model and a narrative review rather than randomized controlled trials — and one included study examined probiotics in fish rather than humans, which limits its direct relevance, so while the direction of findings is broadly supportive, stronger human clinical evidence would be needed to draw firm conclusions.